Cite
HARVARD Citation
Brown, D. et al. (2018). A Phase IC Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Cognitive Outcomes of BI 409306 in Patients with Mild-to-Moderate Schizophrenia. Neurology and therapy. 7 (1), pp. 129-139. [Online].